AMAG Inks $7.5M Deal In Suit Over Preterm-Birth Drug
By Rae Ann Varona · May 8, 2025, 10:37 PM EDT
AMAG Pharmaceuticals has agreed to pay $7.5 million to resolve a group of women's proposed class action accusing it of misleading consumers into believing one of its drugs reduced the risk...
To view the full article, register now.